All In MedTech

Device Trial Radar · NCT00590889

Artificial Valve Endocarditis Reduction Trial

Last checked: Nov 20, 2026Latest source record: Feb 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 807 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

807

Actual

Start

Jul 1998

Primary completion

Sep 2014

Study completion Sep 2014

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
Collaborators
University of Pittsburgh
First posted
Jan 11, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate whether the Silzone coated sewing cuff reduces the incidence of prosthetic valve endocarditis (PVE).

Conditions

  • Aortic Valve Disease
  • Mitral Valve Disease
  • Endocarditis

Interventions

  • Artificial Mechanical Heart ValveDevice

    Both arms used market released mechanical heart valves in accordance with approved labeling

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Prosthetic Valve Endocarditis Comparing Conventional Valves to Silzone™ Coated Valves.Time frame: 1 year

Locations

16 sites in 8 countries. Site status is shown where the registry gives one.

  • Florida Heart Group

    Orlando, Florida

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Brigham and Womens Hospital

    Boston, Massachusetts

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.